I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Co-delivery of doxorubicin, docosahexaenoic acid, and α-toc..:
Eduardo Burgarelli Lages
;
Renata Salgado Fernandes
;
Juliana de Oliveira Silva
...
http://www.sciencedirect.com/science/article/pii/S0753332220310684. , 2020
Link:
https://doi.org/10.1016/j.biopha.2020.110876
RT Journal T1
Co-delivery of doxorubicin, docosahexaenoic acid, and α-tocopherol succinate by nanostructured lipid carriers has a synergistic effect to enhance antitumor activity and reduce toxicity
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:0870edcf498748cb8c83fbd60abde9f6&Exemplar=1&LAN=DE A1 Eduardo Burgarelli Lages A1 Renata Salgado Fernandes A1 Juliana de Oliveira Silva A1 Ângelo Malachias de Souza A1 Geovanni Dantas Cassali A1 André Luís Branco de Barros A1 Lucas Antônio Miranda Ferreira PB Elsevier YR 2020 K1 Doxorubicin K1 Combination therapy K1 Ion-pairing K1 Synergism K1 Antitumor activity K1 Cardiotoxicity K1 Therapeutics. Pharmacology K1 RM1-950 JF http://www.sciencedirect.com/science/article/pii/S0753332220310684 LK http://dx.doi.org/https://doi.org/10.1016/j.biopha.2020.110876 DO https://doi.org/10.1016/j.biopha.2020.110876 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)